Le Lézard
Classified in: Health
Subject: PER

Otoharmonics Appoints Senior Vice President of Sales


PORTLAND, Ore., Oct. 13, 2017 /PRNewswire/ -- Otoharmonics continues to expand its sales leadership team with the hire of Joel Ellis, Senior Vice President of Sales. Fulfilling the latest step in Otoharmonics' growth strategy, Joel joins the team with over 20 years of experience in healthcare.

"With the Levo System's reputation as the new gold standard in tinnitus care, it's only fitting to bring an executive-level sales professional of Joel's caliber," said Michael Baker, President and CEO of Otoharmonics. "With Joel on board, the company is well positioned to broaden our reach within North America, UK and rest of world."

Joel has over two decades of experience in the healthcare field as a sales manager and senior executive, including experience in the hearing healthcare field where he served as National Sales Manager and VP of Managed Care for Beltone Electronics. Additionally, Joel functioned as Senior VP of Sales for AHAA (American Hearing Aid Associates), the forerunner for "buying groups" in the otolaryngology and audiology vertical.

"I'm excited to be a part of such a fabulous team," added Joel Ellis, Senior Vice President of Sales. "From day one at Otoharmonics I've been impressed with the willingness of people throughout the organization to support each other towards the common goal of bringing life-changing therapy to tinnitus patients."

Utilizing an FDA-cleared evidence-based approach, the Levo System offers a patented method to provide personalized sound therapy while sleeping. A soon to be released randomized study by the National Center for Rehabilitative Auditory Research team led by James Henry, Ph.D. at the VA Portland Health Care System demonstrated improved clinical outcomes for tinnitus patients using the Levo System.

To learn more about the Levo System visit http://otoharmonics.com.

About Otoharmonics Corporation

Otoharmonics Corporation is a privately held company with headquarters in Portland, Oregon USA.  An international team of world-class neuroscientists, clinicians, business professionals and patients, Otoharmonics has developed the patented Levo System for the management of tinnitus symptoms. With a personal approach and a deep understanding of the impact tinnitus can have, Levo is designed to be user-friendly and capable of delivering custom sound therapy based on the specific needs of the individual.

Otoharmonics and Levo are registered trademarks of Otoharmonics Corporation.

Contact:
Brenda Edin
Otoharmonics Corporation
Portland, OR
[email protected]
503-336-9906

SOURCE Otoharmonics


These press releases may also interest you

at 00:05
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...

at 00:05
The Insurance Institute for Highway Safety is updating its vehicle-to-vehicle front crash prevention test to address crashes that occur at higher speeds and those in which the struck vehicle is a motorcycle or large truck. Only one of the first 10...

at 00:00
Nutriessential.com recently announced its expansion into Oceania, Asia, and the Gulf. The company has been providing science-backed GMP-certified supplements in the US, Europe and Canada since 2005 and decided to expand owing to rising global demands...

24 avr 2024
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...



News published on and distributed by: